BlossomHill Therapeutics
Latest funding:$84.0M · Series B (December 10, 2025)
Angel investors who backed BlossomHill Therapeutics
26 investors in our database backed BlossomHill Therapeutics.
David Bonita
General Partner
Chau Khuong
Partner
Peter Thompson
Affiliate Professor, Neurosurgery
Scotland Stevens
General Partner
Rishi Gupta
Partner
Geoffrey Hsu
General Partner
Carter Neild
Managing Partner
Carl Gordon
Managing Partner
Erez Chimovits
Managing Director
Mona Ashiya
Private Equity Partner
Anat Naschitz
Managing Director
Nissim Darvish
Senior Managing Director
Jonathan Wang
Partner
Matthew Rizzo
Partner
Sven Borho
Managing Partner
Jonathan Silverstein
Managing Partner
Albert Cha
Chairman
Frank Kung
Co-Founder and Managing Partner
Gaurav Aggarwal
Chief Investment Officer - Opportunity Fund
Michael Chang
Managing Partner
Nina Feng
Principal
Lawrence Wang
Managing Director
Mahendra Shah
Managing Director
Andrew Goldberg
Principal
Chen Yu
Managing Partner
Qi Zhu
Head of Talent Development
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like BlossomHill Therapeutics.
Search investors